
Odonate Therapeutics, Inc. – OTC:ODTC
Odonate Therapeutics stock price today
Odonate Therapeutics stock price monthly change
Odonate Therapeutics stock price quarterly change
Odonate Therapeutics stock price yearly change
Odonate Therapeutics key metrics
Market Cap | 69.28M |
Enterprise value | N/A |
P/E | -0.67 |
EV/Sales | N/A |
EV/EBITDA | 0.21 |
Price/Sales | N/A |
Price/Book | 0.95 |
PEG ratio | -0.12 |
EPS | 15277.97 |
Revenue | N/A |
EBITDA | -17.78M |
Income | -2.47M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOdonate Therapeutics stock price history
Odonate Therapeutics stock forecast
Odonate Therapeutics financial statements
Jun 2021 | 0 | -22.48M | |
---|---|---|---|
Sep 2021 | 0 | -23.93M | |
Sep 2022 | 0 | 39.19M | |
Dec 2022 | 0 | 4.75M |
Dec 2020 | 167886000 | 31.74M | 18.91% |
---|---|---|---|
Mar 2021 | 142879000 | 37.57M | 26.3% |
Jun 2021 | 118573000 | 33.94M | 28.63% |
Sep 2021 | 105773000 | 34.40M | 32.52% |
Mar 2021 | -24.90M | -21K | 825K |
---|---|---|---|
Jun 2021 | -23.02M | -5K | 0 |
Sep 2021 | -15.09M | 0 | 0 |
Dec 2022 | 5.47M | -37.39M | 0 |
Odonate Therapeutics alternative data
Aug 2023 | 137 |
---|---|
Sep 2023 | 137 |
Oct 2023 | 137 |
Nov 2023 | 137 |
Dec 2023 | 137 |
Jan 2024 | 137 |
Feb 2024 | 137 |
Mar 2024 | 137 |
Apr 2024 | 137 |
May 2024 | 137 |
Jun 2024 | 137 |
Jul 2024 | 137 |
Odonate Therapeutics other data
-
What's the price of Odonate Therapeutics stock today?
One share of Odonate Therapeutics stock can currently be purchased for approximately $1.8.
-
When is Odonate Therapeutics's next earnings date?
Unfortunately, Odonate Therapeutics's (ODTC) next earnings date is currently unknown.
-
Does Odonate Therapeutics pay dividends?
No, Odonate Therapeutics does not pay dividends.
-
How much money does Odonate Therapeutics make?
Odonate Therapeutics has a market capitalization of 69.28M.
-
What is Odonate Therapeutics's stock symbol?
Odonate Therapeutics, Inc. is traded on the OTC under the ticker symbol "ODTC".
-
What is Odonate Therapeutics's primary industry?
Company operates in the Financial Services sector and Shell Companies industry.
-
How do i buy shares of Odonate Therapeutics?
Shares of Odonate Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Odonate Therapeutics have?
As Jul 2024, Odonate Therapeutics employs 137 workers.
-
When Odonate Therapeutics went public?
Odonate Therapeutics, Inc. is publicly traded company for more then 7 years since IPO on 7 Dec 2017.
-
What is Odonate Therapeutics's official website?
The official website for Odonate Therapeutics is odonate.com.
-
Where are Odonate Therapeutics's headquarters?
Odonate Therapeutics is headquartered at 3 East 28th Street, New York, NY.
-
How can i contact Odonate Therapeutics?
Odonate Therapeutics's mailing address is 3 East 28th Street, New York, NY and company can be reached via phone at +33 22060935.
Odonate Therapeutics company profile:

Odonate Therapeutics, Inc.
odonate.comOTC
137
Shell Companies
Financial Services
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.
New York, NY 10016
CIK: 0001717452
ISIN: US6760791060
CUSIP: 676079106